1. Home
  2. LGND
  3. LGND News

Latest Ligand Pharmaceuticals Incorporated (LGND) News on December 18, 2024

LGND: 2025 View Calls for 17% Topline Growth
LGND

Zacks Small Cap Research

2 days ago

LGND: 2025 View Calls for 17% Topline Growth

Ligand price target raised to $151 from $135 at Oppenheimer
LGND

TipRanks

6 days ago

Ligand price target raised to $151 from $135 at Oppenheimer

LGND

MT Newswires

7 days ago

Oppenheimer Adjusts Ligand Pharmaceuticals Price Target to $151 From $135, Maintains Outperform Rating

LGND

MT Newswires

7 days ago

RBC Raises Price Target on Ligand Pharmaceuticals to $143 From $141, Keeps Outperform Rating

LGND

Argus Research

8 days ago

LGND: Lowering target price to $125.00

LGND

MT Newswires

8 days ago

Ligand Pharmaceuticals Issues 2025 Guidance; 2024 Forecast Reaffirmed

Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance
LGND

Business Wire

8 days ago

Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance

LGND

Argus Research

15 days ago

LGND: Lowering target price to $126.00

LGND

MT Newswires

15 days ago

RBC Lifts Price Target on Ligand Pharmaceuticals to $141 From $140, Keeps Outperform Rating

Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings
LGND

Simply Wall St.

a month ago

Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings

Ligand to Present at Stifel 2024 Healthcare Conference
LGND

Business Wire

a month ago

Ligand to Present at Stifel 2024 Healthcare Conference

LGND

Argus Research

a month ago

LGND: Raising target price to $127.00

LGND: 3Q Sales Surprise to the Upside
LGND

Zacks Small Cap Research

a month ago

LGND: 3Q Sales Surprise to the Upside

Ligand Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
LGND

Simply Wall St.

a month ago

Ligand Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Intrinsic Value Is Potentially 99% Above Its Share Price
LGND

Simply Wall St.

a month ago

Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Intrinsic Value Is Potentially 99% Above Its Share Price

Ligand Pharmaceuticals Inc (LGND) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
LGND

GuruFocus.com

a month ago

Ligand Pharmaceuticals Inc (LGND) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

LGND

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Late Afternoon

LGND

MT Newswires

a month ago

Ligand Shares Rise After Q3 Tops Expectations, Guidance Raised

LGND

Associated Press Finance

a month ago

Ligand: Q3 Earnings Snapshot

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
LGND

Business Wire

a month ago

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Ligand Pharmaceuticals Inc (LGND) Q3 2024: Everything You Need To Know Ahead Of Earnings
LGND

GuruFocus.com

a month ago

Ligand Pharmaceuticals Inc (LGND) Q3 2024: Everything You Need To Know Ahead Of Earnings

LGND

Argus Research

a month ago

LGND: Lowering target price to $117.00

Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston
LGND

Business Wire

2 months ago

Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston

Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024
LGND

Business Wire

2 months ago

Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
LGND

GlobeNewswire

2 months ago

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer

Ligand Pharmaceuticals Inc (LGND) Q2 2024 Earnings Call Highlights: Robust Revenue Growth Amid ...
LGND

GuruFocus.com

2 months ago

Ligand Pharmaceuticals Inc (LGND) Q2 2024 Earnings Call Highlights: Robust Revenue Growth Amid ...

LGND: Initiating Coverage – A Prince Among Royalty
LGND

Zacks Small Cap Research

2 months ago

LGND: Initiating Coverage – A Prince Among Royalty

LGND

Argus Research

2 months ago

LGND: Raising target price to $108.00

LGND

MT Newswires

3 months ago

Oppenheimer Initiates Ligand Pharmaceuticals at Outperform With $135 Price Target

Can Mixed Fundamentals Have A Negative Impact on Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Current Share Price Momentum?
LGND

Simply Wall St.

3 months ago

Can Mixed Fundamentals Have A Negative Impact on Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Current Share Price Momentum?

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
LGND

Business Wire

3 months ago

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

LGND

Argus Research

4 months ago

LGND: Raising target price to $112.00

Insider Sale: President & COO Matthew Korenberg Sells 18,858 Shares of Ligand ...
LGND

GuruFocus.com

4 months ago

Insider Sale: President & COO Matthew Korenberg Sells 18,858 Shares of Ligand ...

LGND

Argus Research

4 months ago

LGND: Raising target price to $110.00

Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
LGND

Business Wire

4 months ago

Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference

Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings
LGND

Simply Wall St.

4 months ago

Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings

Private Capital's Strategic Moves Highlight Ligand Pharmaceuticals in Q2 2024
LGND

GuruFocus.com

4 months ago

Private Capital's Strategic Moves Highlight Ligand Pharmaceuticals in Q2 2024

LGND

MT Newswires

4 months ago

Ligand Pharmaceuticals Insider Sold Shares Worth $1,797,133, According to a Recent SEC Filing

Insider Buying: CEO Todd Davis Acquires Shares of Ligand Pharmaceuticals Inc (LGND)
LGND

GuruFocus.com

4 months ago

Insider Buying: CEO Todd Davis Acquires Shares of Ligand Pharmaceuticals Inc (LGND)

Ligand Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
LGND

Simply Wall St.

4 months ago

Ligand Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

LGND

MT Newswires

4 months ago

Ligand Pharmaceuticals Q2 Adjusted Earnings Fall, Revenue Increases; Reaffirms Full-Year Guidance

How These Two Lesser-Known Biotech Names Obliterated Sales Expectations
LGND

Investor's Business Daily

4 months ago

How These Two Lesser-Known Biotech Names Obliterated Sales Expectations

LGND

Associated Press Finance

4 months ago

Ligand: Q2 Earnings Snapshot

Ligand Reports Second Quarter 2024 Financial Results
LGND

Business Wire

4 months ago

Ligand Reports Second Quarter 2024 Financial Results

LGND

MT Newswires

4 months ago

Ligand Pharmaceuticals COO Matthew Korenberg to Step Down

Hidden Gems Undiscovered Companies with Strong Fundamentals For July 2024
LGND

Simply Wall St.

5 months ago

Hidden Gems Undiscovered Companies with Strong Fundamentals For July 2024

Undiscovered Gems In The United States For July 2024
LGND

Simply Wall St.

5 months ago

Undiscovered Gems In The United States For July 2024

LGND

MT Newswires

5 months ago

RBC Initiates Ligand Pharmaceuticals at Outperform With $130 Price Target

LGND

Argus Research

5 months ago

LGND: Raising target price to $107.00

Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024
LGND

Business Wire

5 months ago

Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024

LGND

Argus Research

5 months ago

LGND: Raising target price to $104.00

LGND

Argus Research

5 months ago

LGND: Raising target price to $96.00

Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m
LGND

Pharmaceutical Technology

5 months ago

Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m

LGND

MT Newswires

5 months ago

Ligand to Acquire Apeiron for $100 Million in Cash, Plus Up to $28 Million Based on Royalties

Ligand to buy Apeiron; Roche reports another TIGIT setback
LGND

BioPharma Dive

5 months ago

Ligand to buy Apeiron; Roche reports another TIGIT setback

Ligand to Acquire APEIRON Biologics AG for $100 Million
LGND

Business Wire

5 months ago

Ligand to Acquire APEIRON Biologics AG for $100 Million

LGND

Argus Research

6 months ago

LGND: Raising target price to $89.00

Lifecore Biomedical Announces Cooperation Agreement with 22NW
LGND

GlobeNewswire

6 months ago

Lifecore Biomedical Announces Cooperation Agreement with 22NW

LGND

MT Newswires

6 months ago

Ligand Pharmaceuticals' Partner Gets US FDA Approval for Ohtuvayre to Treat Chronic Obstructive Pulmonary Disease

Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
LGND

Business Wire

6 months ago

Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years

Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
LGND

Zacks

6 months ago

Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer

Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
LGND

Zacks

6 months ago

Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?

Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics
LGND

Zacks

6 months ago

Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics

The past three years for Ligand Pharmaceuticals (NASDAQ:LGND) investors has not been profitable
LGND

Simply Wall St.

6 months ago

The past three years for Ligand Pharmaceuticals (NASDAQ:LGND) investors has not been profitable

LGND

MT Newswires

6 months ago

Merck Receives FDA Approval for Capvaxive, Triggers $2 Million Payment for Ligand Pharmaceuticals

Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
LGND

Business Wire

6 months ago

Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults

Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
LGND

Zacks

6 months ago

Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study

Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
LGND

Zacks

6 months ago

Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment

Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
LGND

Zacks

6 months ago

Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro

Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
LGND

Zacks

6 months ago

Shattuck (STTK) Announces Positive Interim Data on Cancer Drug

What Makes Ligand (LGND) a New Strong Buy Stock
LGND

Zacks

6 months ago

What Makes Ligand (LGND) a New Strong Buy Stock

Why Is Ligand (LGND) Up 4% Since Last Earnings Report?
LGND

Zacks

6 months ago

Why Is Ligand (LGND) Up 4% Since Last Earnings Report?

Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect?
LGND

Zacks

6 months ago

Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect?

Recent Price Trend in Ligand (LGND) is Your Friend, Here's Why
LGND

Zacks

6 months ago

Recent Price Trend in Ligand (LGND) is Your Friend, Here's Why

Ligand to Participate in Upcoming Investor Conferences
LGND

Business Wire

7 months ago

Ligand to Participate in Upcoming Investor Conferences

AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
LGND

Zacks

7 months ago

AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030

Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies
LGND

Zacks

7 months ago

Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
LGND

Zacks

7 months ago

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
LGND

Zacks

7 months ago

BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why

Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
LGND

Zacks

7 months ago

Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
LGND

Zacks

7 months ago

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Ionis (IONS), Biogen Down on Ending Development of ALS Drug
LGND

Zacks

7 months ago

Ionis (IONS), Biogen Down on Ending Development of ALS Drug

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
LGND

Zacks

7 months ago

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
LGND

Zacks

7 months ago

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

Insider Sale: President & Chief Operating Officer Matthew Korenberg Sells Shares of Ligand ...
LGND

GuruFocus.com

7 months ago

Insider Sale: President & Chief Operating Officer Matthew Korenberg Sells Shares of Ligand ...

FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
LGND

Zacks

7 months ago

FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
LGND

Zacks

7 months ago

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
LGND

Zacks

7 months ago

Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals

Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
LGND

Zacks

7 months ago

Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility

Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
LGND

Zacks

7 months ago

Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales

LGND

MT Newswires

7 months ago

Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing

Ligand (LGND) Moves to Strong Buy: Rationale Behind the Upgrade
LGND

Zacks

7 months ago

Ligand (LGND) Moves to Strong Buy: Rationale Behind the Upgrade

Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
LGND

Zacks

7 months ago

Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine

Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
LGND

Zacks

7 months ago

Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study

Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
LGND

Zacks

7 months ago

Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates

Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
LGND

Zacks

7 months ago

Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
LGND

Zacks

7 months ago

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
LGND

Zacks

7 months ago

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

Ligand (LGND) Is a Great Choice for 'Trend' Investors, Here's Why
LGND

Zacks

7 months ago

Ligand (LGND) Is a Great Choice for 'Trend' Investors, Here's Why

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
LGND

Zacks

7 months ago

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

Share on Social Networks: